Novo Nordisk’s Fight Against Ozempic Counterfeits
The diabetes drug Ozempic has been a hit for manufacturer Novo Nordisk. But its meteoric rise in popularity brings with it concerns for the patent holder due to emerging reports of patient harm and the widespread availability of counterfeit versions …